ROMIDEPSIN
romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack
ROMIDEPSIN (15387W)
15387W
Manner of administration:Injection
Restriction
Indication: Relapsed or chemotherapy refractory Peripheral T-cell Lymphoma
Treatment phase: Initial treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 40 mg | # of repeats: 5 | DPMA: $4,985.64 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| ROMIDEPSIN-REACH
(romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack)
|
||||
